Ophthalmology
Volume 118, Issue 2 , Pages 332-338 , February 2011

Development of a Risk Score for Geographic Atrophy in Complications of the Age-related Macular Degeneration Prevention Trial

Presented in part: at the meeting of the Association for Research and Vision in Ophthalmology, May 4, 2009, Fort Lauderdale, Florida.

  • Gui-shuang Ying, PhD

      Affiliations

    • Corresponding Author InformationCorrespondence: Gui-shuang Ying, PhD, CAPT Coordinating Center, University of Pennsylvania, 3535 Market Street, Suite 700, Philadelphia, PA 19104-3309
    • ,
  • Maureen G. Maguire, PhD
    • ,
  • Complications of Age-related Macular Degeneration Prevention Trial Research Group

      Affiliations

    • A listing of the Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group appeared in Complications of Age-related Macular Degeneration Prevention Trial Research Group. Laser treatment in patients with bilateral drusen: The Complications of Age-related Macular Degeneration Prevention Trial (CAPT). Ophthalmology 2006;113:1974-86.

Received 22 December 2009 ,Revised 21 June 2010 ,Accepted 23 June 2010.

References 

  1. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond). 1988;2:552–577
  2. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–572
  3. Brown DM, Kaiser PK, Michels M, et al. ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432–1444
  4. Rosenfeld PJ, Brown DM, Heier JS, et al. ANCHOR Study Group Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–1431
  5. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108:697–704
  6. Cong RH, Zhou B, Su QM, et al. Smoking and the risk of age-related macular degeneration: a meta-analysis. Ann Epidemiol. 2008;18:647–656
  7. Age-Related Eye Disease Study Research Group. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report no. 19. Ophthalmology. 2005;112:533–539
  8. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 17. Arch Ophthalmol. 2005;123:1484–1498
  9. Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group. Risk factors for choroidal neovascularization and geographic atrophy in the Complications of Age-related Macular Degeneration Prevention Trial. Ophthalmology. 2008;115:1474–1479
  10. Ying GS, Maguire MG, Alexander J, et al. Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Prevention Trial. Arch Ophthalmol. 2009;127:1147–1151
  11. Tan JS, Mitchell P, Kifley A, et al. Smoking and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch Ophthalmol. 2007;125:1089–1095
  12. Tomany SC, Wang JJ, van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004;111:1280–1287
  13. Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2003;110:1273–1280
  14. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol. 2004;137:486–495
  15. Klein R, Knudtson MD, Cruickshanks KJ, Klein BE. Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol. 2008;126:115–121
  16. Seddon JM, Francis PJ, George S, et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA. 2007;297:1793–1800
  17. Yates JR, Sepp T, Matharu BK, et al. Genetic Factors in AMD Study Group Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med. 2007;357:553–561
  18. Seddon JM, Reynolds R, Maller J, et al. Prediction model for prevalence and incidence of age-related macular degeneration based on genetic, demographic and environmental variables. Invest Ophthalmol Vis Sci. 2009;50:2044–2053
  19. Ying GS, Maguire MG, Liu CC, Antoszyk AN Complications of Age-related Macular Degeneration Prevention Trial Research Group. Night vision symptoms and progression of age-related macular degeneration (AMD) in the Complications of Age-related Macular Degeneration Prevention Trial. Ophthalmology. 2008;115:1876–1882
  20. D'Agostino RB, Grundy S, Sullivan LM, et al. CHD Risk Prediction Group Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286:180–187
  21. Medeiros FA, Weinreb RN, Sample PA, et al. Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma. Arch Ophthalmol. 2005;123:1351–1360
  22. Ocular Hypertension Treatment Study GroupEuropean Glaucoma Prevention Study Group. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology. 2007;114:10–19
  23. Medeiros FA, Weinreb RN. Predictive models to estimate the risk of glaucoma development and progression. Prog Brain Res. 2008;173:15–24
  24. Complications of Age-Related Macular Degeneration Prevention Trial Research Group. The Complications of Age-Related Macular Degeneration Prevention Trial (CAPT): rationale, design and methodology. Clin Trials. 2004;1:91–107
  25. Complications of Age-Related Macular Degeneration Prevention Trial Research Group. Laser treatment in patients with bilateral large drusen: the Complications of Age-Related Macular Degeneration Prevention Trial. Ophthalmology. 2006;113:1974–1986
  26. Age-Related Eye Disease Study Research Group. A simplified severity scale for age-related macular degeneration: AREDS report no. 18. Arch Ophthalmol. 2005;123:1570–1574
  27. Sullivan LM, Massaro JM, D'Agostino RB. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23:1631–1660
  28. Choi B. Slopes of a receiver operating characteristic curve and likelihood ratios for a diagnostic test. Am J Epidemiol. 1998;148:1127–1132
  29. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. In: Monographs on Statistics and Applied Probability. vol. 57:London: Chapman and Hall; 1993;p. 168–177
  30. Margolis DJ, Bilker W, Boston R, et al. Statistical characteristics of area under the receiver operating characteristic curve for a simple prognostic model using traditional and bootstrapped approaches. J Clin Epidemiol. 2002;55:518–524
  31. Brier GW. Verification of weather forecasts expressed in terms of probability. Mon Weather Rev. 1950;78:1–3
  32. Harrell FE, Lee KL, Mark DB. Multivariate prognostic models: issues in developing models, evaluating assumption and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387
  33. Klein ML, Ferris FL, Armstrong J, et al. AREDS Research Group Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology. 2008;115:1026–1031
  34. Altman DG, Royston P. What do we mean by validating a prognostic model?. Stat Med. 2000;19:453–473

 Manuscript no. 2009-1747.

 Financial Disclosure(s): The authors have no proprietary or commercial interest in any of the materials discussed in this article.

 Supported by grants EY012211, EY012261, and EY012279, from the National Eye Institute, National Institutes of Health, Department of Health and Human Services.

PII: S0161-6420(10)00702-5

doi: 10.1016/j.ophtha.2010.06.030

Ophthalmology
Volume 118, Issue 2 , Pages 332-338 , February 2011

Article Tools

* Image Usage & Resolution